Title : Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial.

Pub. Date : 2022 May 21

PMID : 35596935






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sildenafil, a phosphodiesterase-5 (PDE-5) inhibitor, might have beneficial effects on pulmonary haemodynamics, cardiac function and exercise capacity in HFrEF and PHT. Sildenafil Citrate phosphodiesterase 5A Homo sapiens
2 Sildenafil, a phosphodiesterase-5 (PDE-5) inhibitor, might have beneficial effects on pulmonary haemodynamics, cardiac function and exercise capacity in HFrEF and PHT. Sildenafil Citrate phosphodiesterase 5A Homo sapiens